APA (7th ed.) Citation

C, C., MC, L., JJ, L., TM, H., IS, L., Y, W., . . . MJ, M. (2022). Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): A multicentre cohort study. The Lancet. Haematology, 9(4), e289. https://doi.org/10.1016/S2352-3026(22)00033-3

Chicago Style (17th ed.) Citation

C, Casulo, et al. "Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Receiving Three or More Lines of Systemic Therapy (LEO CReWE): A Multicentre Cohort Study." The Lancet. Haematology 9, no. 4 (2022): e289. https://doi.org/10.1016/S2352-3026(22)00033-3.

MLA (9th ed.) Citation

C, Casulo, et al. "Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Receiving Three or More Lines of Systemic Therapy (LEO CReWE): A Multicentre Cohort Study." The Lancet. Haematology, vol. 9, no. 4, 2022, p. e289, https://doi.org/10.1016/S2352-3026(22)00033-3.